Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C14H20N2 |
| Molecular Weight | 216.322 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)N(C)CCC1=CNC2=C1C=CC=C2
InChI
InChIKey=KTQJVAJLJZIKKD-UHFFFAOYSA-N
InChI=1S/C14H20N2/c1-11(2)16(3)9-8-12-10-15-14-7-5-4-6-13(12)14/h4-7,10-11,15H,8-9H2,1-3H3
| Molecular Formula | C14H20N2 |
| Molecular Weight | 216.322 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 23:13:40 GMT 2025
by
admin
on
Mon Mar 31 23:13:40 GMT 2025
|
| Record UNII |
JO3SCR302A
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-MiPT
Created by
admin on Mon Mar 31 23:13:40 GMT 2025 , Edited by admin on Mon Mar 31 23:13:40 GMT 2025
|
||
|
WIKIPEDIA |
TiHKAL
Created by
admin on Mon Mar 31 23:13:40 GMT 2025 , Edited by admin on Mon Mar 31 23:13:40 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
96096-52-5
Created by
admin on Mon Mar 31 23:13:40 GMT 2025 , Edited by admin on Mon Mar 31 23:13:40 GMT 2025
|
PRIMARY | |||
|
29935323
Created by
admin on Mon Mar 31 23:13:40 GMT 2025 , Edited by admin on Mon Mar 31 23:13:40 GMT 2025
|
PRIMARY | |||
|
DTXSID901024777
Created by
admin on Mon Mar 31 23:13:40 GMT 2025 , Edited by admin on Mon Mar 31 23:13:40 GMT 2025
|
PRIMARY | |||
|
JO3SCR302A
Created by
admin on Mon Mar 31 23:13:40 GMT 2025 , Edited by admin on Mon Mar 31 23:13:40 GMT 2025
|
PRIMARY | |||
|
Methylisopropyltryptamine
Created by
admin on Mon Mar 31 23:13:40 GMT 2025 , Edited by admin on Mon Mar 31 23:13:40 GMT 2025
|
PRIMARY | MiPT base, unlike many other tryptamines in their freebase form, does not decompose rapidly in the presence of light or oxygen. 10-25 mg is usually taken orally, with effects lasting 4-6 hours. MiPT is said to emphasize psychedelic/entheogenic effects over sensory/hallucinogenic activity. Users report strong mental effects, but few perceptual alterations. MiPT is unscheduled in the United States. It may be considered controlled as an analog of another stimulant, alpha-methyl-tryptamine, but this has not been tested in court. |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
